Australia's new medical device rules open way to full EU MRA (mutual recognition agreement)
This article was originally published in Clinica
Executive Summary
After a series of delays Australia at last implemented its new medical device regulatory system on October 4. The new law removes the obstacles to the EU implementing for its part the mutual recognition agreement (MRA) with Australia. The MRA is already in operation in Australia, where the TGA, the Australian regulatory authority, has issued several certificates to the EU regulatory system. But the EU has said that it would not operate the system until the new Australian medical device law is voted and implemented and in harmony with the EU requirements.
You may also be interested in...
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.